Global Oncology Survey of NCI-Designated Cancer Centers
The Center for Global Health (CGH) periodically fields a survey to all NCI-Designated Cancer Centers to provide a holistic view of global oncology and identify opportunities for cancer research collaboration and cancer control. The surveys have taken place in 2012, 2014, 2018, and 2021.
While NCI is the largest funder of cancer research, the majority of other research is led by cancer centers. The Global Oncology Survey of NCI-Designated Cancer Centers provides valuable data to understand the current state, priorities, and trends of global oncology. CGH does this by:
- requesting information from all 71 NCI-Designated Cancer Centers about their global oncology programs, training offerings, and non-NIH funded global oncology research programs
- analyzing data for the most comprehensive view on global oncology activities
- sharing results with NCI, the cancer centers, and other organizations involved in research, education, and funding for global oncology
Results from the 2018 survey were used to:
- identify collaborators working in countries where a cancer center has a research program
- inform CGH’s strategy to increase training opportunities and strengthen institutional capacity for cancer research in low- and middle-income countries
- provide a reference tool for replication of the survey in other national and regional settings
report analyses of grant portfolios by country and topic, including non-NIH funded projects for a comprehensive picture of global oncology research
Landscape of global oncology research and training at NCI-Designated Cancer Centers: Results of the 2018-2019 Global Oncology Survey
The article Landscape of global oncology research and training at NCI-Designated Cancer Centers: Results of the 2018-2019 Global Oncology Survey, published in the Journal of Global Oncology, describes the global oncology program offerings and projects at NCI-Designated Cancer Centers (NDCCs). Findings of the Survey represent an important benchmark of the dedication of NDCCs to the field of global oncology, and trends in the survey data reflect those seen in recent literature: the field of global oncology is growing, advancing scientific knowledge, contributing to building research and training capacity in low-and middle-income countries, and becoming a desired career path. Importantly, the survey may also serve as a catalyst and convening tool for strategic discussions for practitioners across the global oncology community. As noted in the report, an upcoming opportunity for NDCC and related organizations is the 8th Annual Symposium on Global Cancer Research. At this scientific satellite meeting of the 2020 Annual Consortium of Universities of Global Health on April 17, 2020, participants will discuss trends, gaps, and potential collaborations in global cancer research and control.
2018-2019 Global Oncology Survey of NCI-Designated Cancer Centers Summary Report
The 2018-2019 Global Oncology Survey of NCI-Designated Cancer Centers Summary Report is a collaborative initiative between the National Cancer Institute (NCI), the American Society of Clinical Oncology (ASCO), and the 70 NCI-Designated Cancer Centers across the U.S. to learn about the non-NIH-funded global oncology activities led by NCI-Designated Cancer Centers. This report highlights the non-NIH-funded global oncology programs at Cancer Centers and global oncology projects led by Cancer Centers with international collaborators. It complements what is known about the NIH-funded portfolio, and further highlights NCI-Designated Cancer Centers' commitment to global oncology. The report is intended to facilitate both information sharing and collaboration; and serve as a catalyst for the global oncology community to discuss ways to prioritize and coordinate, where appropriate, in global oncology research and training.
How to Connect
To become involved in the dissemination of 2021 survey results (anticipated in early 2022) or learn more about the global oncology survey methodology and findings, contact email@example.com.
The development and dissemination of the 2021 survey includes advisors from the American Association for Cancer Research, the American Society of Preventive Oncology, and four NCI-Designated Cancer Centers (Dartmouth-Hitchcock Norris Cotton Cancer Center, the University of Texas MD Anderson Cancer Center, Memorial Sloan Kettering Cancer Center, and Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins).